Intervention

Valproic Acid

ClinicalTrials.gov intervention label

Clinical trials6
Recruiting0
Common conditions25
Lead sponsors shown6

Clinical trials

6 shown
LRAs United as a Novel Anti-HIV Strategy.NCT03525730 · 2018-04-18
COMPLETED
Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01
TERMINATED
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseNCT01552434 · 2012-10-16
TERMINATED
Valproic Acid in Subjects With Intact Cognition - Proof of Concept StudyNCT01729598 · 2012-04-01
COMPLETED
Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotNCT01007695 · 2010-05-01
TERMINATED
Valproic Acid and Its Effects on HIV Latent ReservoirsNCT00289952 · 2006-06-01
COMPLETED

Common conditions

Advanced Malignant Neoplasm1Alzheimer's Disease1Anxiety Disorders1Cancer1Castleman Disease1Dementia1Depression1Digestive System Carcinoma1Erdheim-Chester Disease1HIV Infections1HIV-1-infection1Lip and Oral Cavity Carcinoma1Lymphangioleiomyomatosis1Malignant Endocrine Neoplasm1Malignant Female Reproductive System Neoplasm1Malignant Male Reproductive System Neoplasm1Malignant Neoplasm1Malignant Respiratory Tract Neoplasm1Malignant Thoracic Neoplasm1Malignant Urinary System Neoplasm1Mesothelial Neoplasm1Metastatic Malignant Neoplasm1Metastatic Urothelial Carcinoma1Neurofibromatosis Type 21Psychosomatic Disorders1

Trial status mix

COMPLETED3
TERMINATED3

Phase mix

PHASE13
PHASE22
EARLY_PHASE11
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.